Atai Life Sciences N.V. (ATAI)

NASDAQ: ATAI · Real-Time Price · USD

5.78

-0.08 (-1.37%)

At close: Oct 30, 2025, 4:00 PM EDT

5.89

+0.11 (1.90%)

After-hours: Oct 30, 2025, 7:58 PM EDT

Atai Life Sciences Employees

Atai Life Sciences had 54 employees as of December 31, 2024. The number of employees decreased by 29 or -34.94% compared to the previous year.

Employees

54

Change (1Y)

-29

Growth (1Y)

-34.94%

Revenue / Employee

$42,759

Profits / Employee

-$2,211,185

Market Cap

1.24B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	54	-29	-34.94%
Dec 31, 2023	83	-50	-37.59%
Dec 31, 2022	133	46	52.87%
Dec 31, 2021	87	52	148.57%
Dec 31, 2020	35	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

ATAI News

10 days ago - atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares - GlobeNewsWire
10 days ago - Atai Life Sciences And Beckley Psytech: Promising Emerging Leader In Psychedelics - Seeking Alpha
13 days ago - atai Life Sciences Announces Pricing of Public Offering of Common Shares - GlobeNewsWire
14 days ago - atai Life Sciences Announces Proposed Public Offering of Common Shares - GlobeNewsWire
14 days ago - atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression - GlobeNewsWire
17 days ago - Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside - Benzinga
4 weeks ago - Atai Life Sciences: Still A Decent Prospect - But Only Just - Seeking Alpha
5 weeks ago - Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients - Benzinga